Overview
Xiaojing Xu practices in Beijing, China. Xu is rated as an Advanced expert by MediFind in the treatment of Myoclonic Epilepsy. Their top areas of expertise are Landau-Kleffner Syndrome, Myoclonic Epilepsy, Dravet Syndrome, and Benign Familial Neonatal Seizures.
Their clinical research consists of co-authoring 14 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 6 articles in the study of Myoclonic Epilepsy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Landau-Kleffner SyndromeXu isDistinguished. Learn about Landau-Kleffner Syndrome.
- Advanced
- Benign Familial Neonatal Seizures
- Dravet SyndromeXu isAdvanced. Learn about Dravet Syndrome.
- Epilepsy with Myoclonic-Atonic Seizures
- Myoclonic Epilepsy
- Experienced
- Alternating Hemiplegia of Childhood
- EpilepsyXu isExperienced. Learn about Epilepsy.
- Epilepsy in ChildrenXu isExperienced. Learn about Epilepsy in Children.
- Genetic Epilepsy with Febrile Seizures Plus (GEFS+)
- HemiplegiaXu isExperienced. Learn about Hemiplegia.
- MosaicismXu isExperienced. Learn about Mosaicism.